Men with negative mpMRI results avoiding biopsy did not have increased risk for clinically significant prostate cancer.

Patient-centered pathology reports help patients understand prostate cancer results better than standard reports.

Patient-centered pathology reports (PCPR) help patients to understand prostate cancer results better than current stand ...

In one analysis, 16% of men with no suspicious lesions on MRI had clinically significant prostate cancer identified after ...

level ≥4.0 ng/ml is predictive of prostate cancer, and necessitates a biopsy. But there is a dearth of prospective data on the predictive value of PSA levels below this threshold. To analyse the ...

Prostate cancer imaging developed by university researchers has shown “extremely encouraging” results in its first clinical ...

Increasing either the intensity of PSA screening and subsequent biopsy, or the sensitivity of PSA testing would lead to more overdiagnosis and overtreatment of prostate cancer. If all the survival ...

The new test has demonstrated an initial 94% sensitivity rate in tumour detection and the test is delivered in under 20 ...

An ultrasound test that takes less than 20 minutes could improve the accuracy of prostate cancer diagnosis, scientists say.

A prostate cancer imaging breakthrough could cut waiting times after “extremely encouraging” results in its first clinical ...

Metastatic prostate cancer can progress in different ways. In some men the disease advances rapidly, while other men have slower-growing cancer and a better prognosis. Researchers are developing ...

A novel polygenic risk score (PRS) may be useful for identifying men on active surveillance (AS) for prostate cancer who are ...